CTAG2 and triple-negative breast carcinoma: Based on CCLE analysis, triple-negative breast cancer cell lines, such as AU565, HCC1187 and MDAMB453 had high expression in LAGE-1, LAGE2A, LAGE2B and LAGE-3 (Figure 1B).